The Accumulation of the glycoxidation product Nε-carboxymethyllysine in cardiac tissues with age, diabetes mellitus and coronary heart disease

Tohoku Journal of Experimental Medicine

Volumn 230, Issue 1, 2013, Pages 25-32

  Hu, Shengda ^a   He, Wei ^a   Liu, Zhiyong ^a   Xu, Hongzeng ^a   Ma, Genshan ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Advanced glycation end product; Age; Coronary heart disease; Diabetes mellitus; Ne carboxymethyllysine

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT;

ADULT; AGE; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BIOACCUMULATION; CHILD; CONGENITAL HEART DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCATION; HEART SURGERY; HUMAN; HUMAN TISSUE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OXIDATION; PATHOGENESIS; TISSUE LEVEL; VALVULAR HEART DISEASE;

ADOLESCENT; ADULT; AGED; AGING; CHILD; CHILD, PRESCHOOL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; GLYCOSYLATION; HUMANS; INFANT; LYSINE; MALE; MIDDLE AGED; MYOCARDIUM; OXIDATION-REDUCTION; SMOKING; YOUNG ADULT;

EID: 84879062071     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.230.25     Document Type: Article

References (52)

1. Aronson, D. (2003) Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J. Hypertens., 21, 3-12.
2. Asif, M., Egan, J., Vasan, S., Jyothirmayi, G.N., Masurekar, M.R., Lopez, S., Williams, C., Torres, R.L., Wagle, D., Ulrich, P., Cerami, A., Brines, M. & Regan, T.J. (2000) An advanced glycation endproduct cross-link breaker can reverse agerelated increases in myocardial stiffness. Proc. Natl. Acad. Sci. USA, 97, 2809-2813.
3. Avendano, G.F., Agarwal, R.K., Bashey, R.I., Lyons, M.M., Soni, B.J., Jyothirmayi, G.N. & Regan, T.J. (1999) Effects of glucose intolerance on myocardial function and collagenlinked glycation. Diabetes, 48, 1443-1447.
4. Ballinger, M.L., Thomas, M.C., Nigro, J., Ivey, M.E., Dilley, R.J. & Little, P.J. (2005) Glycated and carboxy-methylated proteins do not directly activate human vascular smooth muscle cells. Kidney Int., 68, 2756-2765.
5. Bauters, C., Lamblin, N., McFadden, E.P., Van Belle, E., Millaire, A. & de Groote, P. (2003) Influence of diabetes mellitus on heart failure risk and outcome. Cardiovasc. Diabetol., 2, 1.
6. Beisswenger, P.J., Makita, Z., Curphey, T.J., Moore, L.L., Jean, S., Brinck-Johnsen, T., Bucala, R. & Vlassara, H. (1995) Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes. Diabetes, 44, 824-829.
7. Bierhaus, A., Chevion, S., Chevion, M., Hofmann, M., Quehenberger, P., Illmer, T., Luther, T., Berentshtein, E., Tritschler, H., Muller, M., Wahl, P., Ziegler, R. & Nawroth, P.P. (1997) Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells. Diabetes, 46, 1481-1490.
8. Bierhaus, A., Hofmann, M.A., Ziegler, R. & Nawroth, P.P. (1998) AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc. Res., 37, 586-600.
9. Brener, S.J., Mehran, R., Dressler, O., Cristea, E. & Stone, G.W. (2012) Diabetes mellitus, myocardial reperfusion, and outcome in patients with acute ST-elevation myocardial infarction treated with primary angioplasty (from HORIZONS AMI). Am. J. Cardiol., 109, 1111-1116.
10. Brownlee, M., Cerami, A. & Vlassara, H. (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. New Engl. J. Med., 318, 1315-1321.
11. Burgess, M.L., McCrea, J.C. & Hedrick, H.L. (2001) Age-associated changes in cardiac matrix and integrins. Mech. Ageing Dev., 122, 1739-1756.
12. Candido, R., Forbes, J.M., Thomas, M.C., Thallas, V., Dean, R.G., Burns, W.C., Tikellis, C., Ritchie, R.H., Twigg, S.M., Cooper, M.E. & Burrell, L.M. (2003) A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes. Circ. Res., 92, 785-792.
13. Day, J.J., Bayer, A.J., Chadha, J.S. & Pathy, M.S. (1988) Myocardial infarction in old people. The influence of diabetes mellitus. J. Am. Geriatr. Soc., 36, 791-794.
14. Eble, A.S., Thorpe, S.R. & Baynes, J.W. (1983) Nonenzymatic glucosylation and glucose-dependent cross-linking of protein. J. Biol. Chem., 258, 9406-9412.
15. Fu, M.X., Requena, J.R., Jenkins, A.J., Lyons, T.J., Baynes, J.W. & Thorpe, S.R. (1996) The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J. Biol. Chem., 271, 9982-9986.
16. Fu, S., Fu, M.X., Baynes, J.W., Thorpe, S.R. & Dean, R.T. (1998) Presence of dopa and amino acid hydroperoxides in proteins modified with advanced glycation end products (AGEs): amino acid oxidation products as a possible source of oxidative stress induced by AGE proteins. Biochem. J., 330 (Pt 1), 233-239.
17. Fujiwara, K., Hiasa, Y., Takahashi, T., Yamaguchi, K., Ogura, R., Ohara, Y., Nada, T., Ogata, T., Yuba, K., Kusunoki, K., Hosokawa, S., Kishi, K. & Ohtani, R. (2002) Influence of diabetes mellitus on outcome in the era of primary stenting for acute myocardial infarction. Circ. J., 66, 800-804.
18. Hammes, H.P., Brownlee, M., Lin, J., Schleicher, E. & Bretzel, R.G. (1999) Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Nepsilon-(carboxymethyl) lysine independently of glycohaemoglobin concentrations. Diabetologia, 42, 603-607.
19. Hartog, J.W., Voors, A.A., Schalkwijk, C.G., Scheijen, J., Smilde, T.D., Damman, K., Bakker, S.J., Smit, A.J. & van Veldhuisen, D.J. (2007) Clinical and prognostic value of advanced glycation end-products in chronic heart failure. Eur. Heart J., 28, 2879-2885.
20. Hirakawa, Y., Masuda, Y., Kuzuya, M., Iguchi, A., Kimata, T. & Uemura, K. (2007) Influence of diabetes mellitus on in-hospital mortality in patients with acute myocardial infarction in Japan: a report from TAMIS-II. Diabetes Res. Clin. Pr., 75, 59-64.
21. Huijberts, M.S., Wolffenbuttel, B.H., Boudier, H.A., Crijns, F.R., Kruseman, A.C., Poitevin, P. & Levy, B.I. (1993) Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats. J. Clin. Invest., 92, 1407-1411.
22. Iribarren, C., Karter, A.J., Go, A.S., Ferrara, A., Liu, J.Y., Sidney, S. & Selby, J.V. (2001) Glycemic control and heart failure among adult patients with diabetes. Circulation, 103, 2668-2673.
23. Jensen, L.O., Maeng, M., Thayssen, P., Tilsted, H.H., Terkelsen, C.J., Kaltoft, A., Lassen, J.F., Hansen, K.N., Ravkilde, J., Christiansen, E.H., Madsen, M., Sorensen, H.T. & Thuesen, L. (2012) Influence of diabetes mellitus on clinical outcomes following primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Am. J. Cardiol., 109, 629-635.
24. Kass, D.A., Shapiro, E.P., Kawaguchi, M., Capriotti, A.R., Scuteri, A., de Groof, R.C. & Lakatta, E.G. (2001) Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation, 104, 1464-1470.
25. Kislinger, T., Fu, C., Huber, B., Qu, W., Taguchi, A., Du Yan, S., Hofmann, M., Yan, S.F., Pischetsrieder, M., Stern, D. & Schmidt, A.M. (1999) N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J. Biol. Chem., 274, 31740-31749.
26. Kislinger, T., Tanji, N., Wendt, T., Qu, W., Lu, Y., Ferran, L.J. Jr., Taguchi, A., Olson, K., Bucciarelli, L., Goova, M., Hofmann, M.A., Cataldegirmen, G., D'Agati, V., Pischetsrieder, M., Stern, D.M. & Schmidt, A.M. (2001) Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice. Arterioscler. Thromb. Vasc. Biol., 21, 905-910.
27. Kralev, S., Zimmerer, E., Brueckmann, M., Lang, S., Kalsch, T., Rippert, A., Lin, J., Borggrefe, M., Hammes, H.P. & Suselbeck, T. (2009) Elevation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in patients presenting with acute myocardial infarction. Clin. Chem. Lab. Med., 47, 446-451.
28. Lander, H.M., Tauras, J.M., Ogiste, J.S., Hori, O., Moss, R.A. & Schmidt, A.M. (1997) Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogenactivated protein kinase pathway regulated by oxidant stress. J. Biol. Chem., 272, 17810-17814.
29. Lieuw-a-Fa, M.L., Schalkwijk, C.G., Engelse, M. & van Hinsbergh, V.W. (2006) Interaction of Nepsilon(carboxymethyl)lysineand methylglyoxal-modified albumin with endothelial cells and macrophages. Splice variants of RAGE may limit the responsiveness of human endothelial cells to AGEs. Thromb. Haemostasis, 95, 320-328.
30. Liu, J., Masurekar, M.R., Vatner, D.E., Jyothirmayi, G.N., Regan, T.J., Vatner, S.F., Meggs, L.G. & Malhotra, A. (2003) Glycation end-product cross-link breaker reduces collagen and improves cardiac function in aging diabetic heart. Am. J. Physiol. Heart Circ. Physiol., 285, H2587-2591.
31. Mak, K.H., Moliterno, D.J., Granger, C.B., Miller, D.P., White, H.D., Wilcox, R.G., Califf, R.M. & Topol, E.J. (1997) Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J. Am. Coll. Cardiol., 30, 171-179.
32. Makita, Z., Radoff, S., Rayfield, E.J., Yang, Z., Skolnik, E., Delaney, V., Friedman, E.A., Cerami, A. & Vlassara, H. (1991) Advanced glycosylation end products in patients with diabetic nephropathy. New Engl. J. Med., 325, 836-842.
33. McCullough, P.A., Jurkovitz, C.T., Pergola, P.E., McGill, J.B., Brown, W.W., Collins, A.J., Chen, S.C., Li, S., Singh, A., Norris, K.C., Klag, M.J. & Bakris, G.L. (2007) Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP). Arch. Intern. Med., 167, 1122-1129.
34. Nerlich, A.G. & Schleicher, E.D. (1999) N(epsilon)-(carboxymethyl) lysine in atherosclerotic vascular lesions as a marker for local oxidative stress. Atherosclerosis, 144, 41-47.
35. Norton, G.R., Candy, G. & Woodiwiss, A.J. (1996) Aminoguanidine prevents the decreased myocardial compliance produced by streptozotocin-induced diabetes mellitus in rats. Circulation, 93, 1905-1912.
36. Olivetti, G., Melissari, M., Capasso, J.M. & Anversa, P. (1991) Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. Circ. Res., 68, 1560-1568.
37. Peppa, M., Uribarri, J. & Vlassara, H. (2002) Advanced glycoxidation. A new risk factor for cardiovascular disease? Cardiovasc. Toxicol., 2, 275-287.
38. Peppa, M., Uribarri, J. & Vlassara, H. (2004) The role of advanced glycation end products in the development of atherosclerosis. Curr. Diabetes Rep., 4, 31-36.
39. Reddy, S., Bichler, J., Wells-Knecht, K.J., Thorpe, S.R. & Baynes, J.W. (1995) N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry-US., 34, 10872-10878.
40. Sarnak, M.J., Levey, A.S., Schoolwerth, A.C., Coresh, J., Culleton, B., Hamm, L.L., McCullough, P.A., Kasiske, B.L., Kelepouris, E., Klag, M.J., Parfrey, P., Pfeffer, M., Raij, L., Spinosa, D.J. & Wilson, P.W. (2003) Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation, 108, 2154-2169.
41. Schalkwijk, C.G., Baidoshvili, A., Stehouwer, C.D., van Hinsbergh, V.W. & Niessen, H.W. (2004) Increased accumulation of the glycoxidation product Nepsilon-(carboxymethyl)lysine in hearts of diabetic patients: generation and characterisation of a monoclonal anti-CML antibody. Biochim. Biophys. Acta, 1636, 82-89.
42. Schleicher, E.D., Wagner, E. & Nerlich, A.G. (1997) Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. J. Clin. Invest., 99, 457-468.
43. Sell, D.R., Lapolla, A., Odetti, P., Fogarty, J. & Monnier, V.M. (1992) Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM. Diabetes, 41, 1286-1292.
44. Stanislawska, J., Krzymien, J., Opolski, G., Wardaszko, T., Gorecki, A. & Kraska, T. (1993) Influence of diabetes on the clinical course and hospital mortality of patients with recent myocardial infarction. Pol. Arch. Med. Wewn., 89, 56-61.
45. Stitt, A.W., He, C., Friedman, S., Scher, L., Rossi, P., Ong, L., Founds, H., Li, Y.M., Bucala, R. & Vlassara, H. (1997) Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEs. Mol. Med., 3, 617-627.
46. Stratton, I.M., Adler, A.I., Neil, H.A., Matthews, D.R., Manley, S.E., Cull, C.A., Hadden, D., Turner, R.C. & Holman, R.R. (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ, 321, 405-412.
47. Tamarat, R., Silvestre, J.S., Huijberts, M., Benessiano, J., Ebrahimian, T.G., Duriez, M., Wautier, M.P., Wautier, J.L. & Levy, B.I. (2003) Blockade of advanced glycation endproduct formation restores ischemia-induced angiogenesis in diabetic mice. Proc. Natl. Acad. Sci. USA, 100, 8555-8560.
48. Thomas, D.P., McCormick, R.J., Zimmerman, S.D., Vadlamudi, R.K. & Gosselin, L.E. (1992) Aging-and training-induced alterations in collagen characteristics of rat left ventricle and papillary muscle. Am. J. Physiol.-Heart C., 263, H778-783.
49. Weber, K.T., Brilla, C.G. & Janicki, J.S. (1993) Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc. Res., 27, 341-348.
50. Wolffenbuttel, B.H., Boulanger, C.M., Crijns, F.R., Huijberts, M.S., Poitevin, P., Swennen, G.N., Vasan, S., Egan, J.J., Ulrich, P., Cerami, A. & Levy, B.I. (1998) Breakers of advanced glycation end products restore large artery properties in experimental diabetes. Proc. Natl. Acad. Sci. USA, 95, 4630-4634.
51. Yeh, C.H., Sturgis, L., Haidacher, J., Zhang, X.N., Sherwood, S.J., Bjercke, R.J., Juhasz, O., Crow, M.T., Tilton, R.G. & Denner, L. (2001) Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factorkappaB transcriptional activation and cytokine secretion. Diabetes, 50, 1495-1504.
52. Zieman, S.J. & Kass, D.A. (2004) Advanced glycation endproduct crosslinking in the cardiovascular system: potential therapeutic target for cardiovascular disease. Drugs, 64, 459-470.